NCT02980198View on ClinicalTrials.gov

Study of IFN-K in Dermatomyositis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 3, 2017

Primary Completion Date

December 11, 2019

Study Completion Date

December 11, 2019

Conditions
Dermatomyositis
Interventions
BIOLOGICAL

IFN-Kinoid

IM administration

OTHER

Placebo

IM administration

OTHER

ISA 51

adjuvant

Trial Locations (8)

1011

Research site, Lausanne

10117

Charité - Universitätsmedizin Berlin Rudolf- Virchow- Haus, Berlin

13354

Research site, Marseille

35128

Research site, Padua

59037

Research site, Lille

67098

Research site, Strasbourg

75010

Research site, Paris

75013

Research site, Paris

Sponsors

Lead Sponsor

Neovacs
All Listed Sponsors
lead

Neovacs

INDUSTRY

NCT02980198 - Study of IFN-K in Dermatomyositis | Biotech Hunter | Biotech Hunter